Limaresiquimod

Approval Year

Substance Class	Polymer Created by `admin` on `Sat Dec 16 20:00:20 GMT 2023` Edited by `admin` on `Sat Dec 16 20:00:20 GMT 2023`
Record UNII	2N985J9XZZ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Limaresiquimod

Official Name

English

limaresiquimod [INN]

Common Name

English

acetyl and 1-{[2-(ethoxymethyl)-1-(2-hydroxy-2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-yl]amino}-1,4,14-trioxo-6,9,12-trioxa-3,15-diazaoctadecan-18-oyl groups linked to 11 and 8 percent of amino end groups, respectively, of the dendritic block polymer

Common Name

English

L-Lysine, polymer with oxirane, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1), diblock, polymer with α-(5-carboxy-1-oxopentyl)-ω-[(5-carboxy-1-oxopentyl)oxy]poly(oxy-1,2-ethanediyl), reaction products with acetic anhydride and 18-[[2-(ethoxym

Common Name

English

Code System Code Type Description

FDA UNII

2N985J9XZZ

Created by admin on Sat Dec 16 20:00:20 GMT 2023 , Edited by admin on Sat Dec 16 20:00:20 GMT 2023

PRIMARY

CAS

2762923-39-5

Created by admin on Sat Dec 16 20:00:20 GMT 2023 , Edited by admin on Sat Dec 16 20:00:20 GMT 2023

PRIMARY

INN

12722

Created by admin on Sat Dec 16 20:00:20 GMT 2023 , Edited by admin on Sat Dec 16 20:00:20 GMT 2023

PRIMARY

Related Record Type Details


					2N985J9XZZ

Limaresiquimod

ACTIVE MOIETY

Comments:

immunomodulator, antineoplastic

Amount: